Compare International Business Machines Corp (IBM) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Business Machines Corp vs Tempus AI — how do they compare? International Business Machines Corp trades at $226.25 (market cap $207.75B), while Tempus AI trades at $70.59 (market cap $12.77B). The key difference: International Business Machines Corp is far larger — about 16.3× Tempus AI's market cap, and International Business Machines Corp pays a 3.07% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 88 Days and Tempus AI for 22 Days on average.
| IBM | TEM | |
|---|---|---|
Market Cap | $207.75B | $12.77B |
Volume | 3,864,661 | 8,980,490 |
Sector | Technology | Broad Market / Factor |
52-Week High | $329.23 | $99.28 |
52-Week Low | $205.77 | $41.55 |
Typical Hold Time | 88 Days | 22 Days |
Enterprise Value | $264.89B | $13.40B |
Dividend Yield | 3.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBM's stock trades at $220.51, down 0.35% on the day, amid a bearish technical signal. The company reported strong 2025 results with revenue of $67.54B and net income of $10.59B, beating earnings expectations in recent quarters. Analyst consensus is a Buy with a $256.69 price target, though technical indicators show resistance near $222. Recent news highlights IBM's focus on AI, including self-hosted deployment for its Bob platform.
IBM presents a mixed outlook with solid fundamentals and AI growth potential offset by near-term technical weakness and competitive pressures. The stock's valuation appears reasonable with a P/E of 19.58, but investors face risks from execution challenges and market volatility. Upside hinges on sustained earnings growth and successful AI integration.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
